Flow Traders U.S.
HELX icon

Flow Traders U.S.’s Franklin Genomic Advancements ETF HELX Stock Holding History

Flow Traders U.S.’s Portfolio HELX Stock Details HELX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.86M Buy
+41,652
New +$1.72M 0.05% 277
2022
Q1 		– Sell
-6,488
Closed -$315K – 872
2021
Q4 		$315K Hold
6,488
– – 0.02% 597
2021
Q3 		$339K Sell
6,488
-225
-3% -$12.2K 0.01% 802
2021
Q2 		$348K Hold
6,713
– – 0.02% 697
2021
Q1 		$291K Buy
+6,713
New +$314K 0.02% 656

Other funds holding HELX

Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Harbour Investments
Harbour Investments Madison, Wisconsin $6.75B AUM 16.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
BFCFSI
BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. Cedar Rapids, Iowa $374M AUM 26.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Flow Traders U.S.'s HELX Position: Q3 2026 in Review

Flow Traders U.S. opened a new position in Franklin Genomic Advancements ETF (HELX) in Q3 2026: 41,652 shares worth $1.86M. The stake represents 0.05% of the portfolio and ranks #277 among its holdings. This is a return to the name: Flow Traders U.S. previously reported a position in HELX as recently as Q4 2021.

Flow Traders U.S. first reported a position in HELX in Q1 2021 and has held it in 5 quarters since. 8 funds tracked by Wall St. Rank hold HELX as of Q3 2026.

  • Flow Traders U.S. held 41,652 shares of Franklin Genomic Advancements ETF worth $1.86M as of Q3 2026.
  • Franklin Genomic Advancements ETF was a new Flow Traders U.S. position in Q3 2026.
  • Franklin Genomic Advancements ETF made up 0.05% of Flow Traders U.S.'s portfolio in Q3 2026, its #277 holding.
  • Flow Traders U.S. first reported a position in Franklin Genomic Advancements ETF in Q1 2021 and has held it in 5 quarters since.
  • 8 funds tracked by Wall St. Rank held Franklin Genomic Advancements ETF as of Q3 2026.

Based on Flow Traders U.S.'s 13F filing for Q3 2026, filed 13 Nov 2026.